Final results of a randomized comparison of infusional 5-fluorouracil/leucovorin plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) in metastatic colorectal carcinoma (MCRC)

被引：0
|
作者：
Porschen, Rainer
Kubicka, S.
Grothey, A.
Grateven, U.
Kretzschmar, A.
Greil, R.
Freier, W.
Seufferlein, T.
Arkenau, Ht
Hinke, A.
Schmoll, Hj
Schmiegel, W.
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A582 / A582
页数：1
相关论文
共 50 条
  • [1] Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus Capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of the safety and efficacy analysis
    Arkenau, H.
    Kubicka, S.
    Greil, R.
    Schmoll, H.
    Seufferlein, T.
    Greaven, U.
    Grothey, A.
    Kretschmar, A.
    Hinke, A.
    Porschen, R.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 168 - 168
  • [2] Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of a safety and efficacy analysis
    Arkenau, HT
    Schmoll, H
    Kubicka, S
    Kretzschmar, A
    Freier, W
    Seufferlein, T
    Graeven, U
    Grothey, A
    Hinke, A
    Porschen, R
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 283 - 283
  • [3] Infusiorial 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal cancer (MCRC): Results of the safety and efficacy analysis.
    Arkenau, HT
    Schmoll, H
    Kubicka, S
    Kretzschmar, A
    Freier, W
    Seufferlein, T
    Graeven, U
    Grothey, A
    Hinke, A
    Porschen, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 247S - 247S
  • [4] Phase III trial of infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment in advanced colorectal carcinoma (ACRC): Results of an interim safety analysis.
    Arkenau, HT
    Schmoll, H
    Kubicka, S
    Seufferlein, T
    Reichardt, P
    Freier, W
    Graeven, U
    Grothey, A
    Porschen, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 256S - 256S
  • [5] Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer
    YAO Yang
    [J]. 中华医学杂志(英文版), 2006, (21) : 1829 - 1833
  • [6] Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer
    Yao Yang
    Sun Yuan-jue
    Zhao Hui
    Guo Yue-Wu
    Lin Feng
    Cai Xun
    Tang Xiao-chun
    Tang Li-na
    Zhang Wei
    [J]. CHINESE MEDICAL JOURNAL, 2006, 119 (21) : 1829 - 1833
  • [7] Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer
    YAO Yang SUN Yuanjue ZHAO Hui GUO Yuewu LIN Feng CAI Xun TANG Xiaochun TANG Lina and ZHANG Wei Department of Oncology Shanghai Sixth Peoples Hospital of Shanghai Jiaotong University Shanghai China Department of Epidemiology Cancer Research Institute of Shanghai Jiaotong University Shanghai China
    [J]. Chinese Medical Journal., 2006, (21) - 1833
  • [8] Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer
    Ducreux, Michel
    Bennouna, Jaafar
    Hebbar, Mohamed
    Ychou, Marc
    Lledo, Gerard
    Conroy, Thierry
    Adenis, Antoine
    Faroux, Roger
    Rebischung, Christine
    Bergougnoux, Loic
    Kockler, Leila
    Douillard, Jean-Yves
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (03) : 682 - 690
  • [9] Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials
    Arkenau, Hendrik-Tobias
    Arnold, Dirk
    Cassidy, Jim
    Diaz-Rubio, Eduardo
    Douillard, Jean-Yves
    Hochster, Howard
    Martoni, Andrea
    Grothey, Axel
    Hinke, Axel
    Schmiegel, Wolff
    Schmoll, Hans-Joachim
    Porschen, Rainer
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (36) : 5910 - 5917
  • [10] Capecitabine plus oxaliplatin compared with 5-fluorouracil plus oxaliplatin in metastatic colorectal cancer: Meta-analysis of randomized controlled trials
    Zhang, Chengyao
    Wang, Jiawu
    Gu, Haitao
    Zhu, Daihua
    Li, Yang
    Zhu, Peng
    Wang, Yaxu
    Wang, Jijian
    [J]. ONCOLOGY LETTERS, 2012, 3 (04) : 831 - 838
12345